Jean Jeong

Kirkland & Ellis LLP is pleased to announce that 145 attorneys have been promoted to partner effective today. Boston Name Practice Area Payson W. Lyman M&A/Private Equity Dena H. Medford M&A/Private Equity Casey O'Brien Investment Funds Josh Peary Debt Finance Matthew J. Smith Investment Funds Chicago Name Practice Area Joshua M. Altman Restructuring Peter K. Anderson M&A/Private Equity Michael S. Biehl Litigation Mary Liz Brady Debt Finance Katherine Bryan M&A/Private Equity Zachary A. Ciullo Litigation Adria M. Crowe Employee Benefits Margaret R.T. Dewar Tax Rosalyn K. Flores M&A/Private Equity Whitney C. Fogelberg Restructuring Tasha Francis Gerasimow Intellectual Property Litigation Kent J. Hayden Litigation Todd Herst Technology & IP Transactions Sean Hilson Debt Finance Theresa Cederoth Horan Litigation Sam Ikard Litigation Hanaa Kaloti Litigation Christopher S. Koenig Restructuring John Z. Kosir M&A/Private Equity Nikhil R. Krishnan Intellectual Property Litigation Laura Krucks Restructuring Christine M. Lehman Tax Taryn E. Lewis Litigation Rebecca Liu Executive Compensation Erika P. López M&A/Private Equity John R. Luze Restructuring Allison A. Ray Litigation Anne Reser Litigation Erica Rozow Employee Benefits Brendan E. Ryan Litigation Reed T. Schuster Investment Funds Christina E. Sharkey Litigation Austin B. Stephenson Litigation India D. Williams Litigation Dallas Name Practice Area Michael Kalis Litigation Joshua Merrill M&A/Private Equity Rachael A. Rezabek Antitrust/Competition Conrad Steele Real Estate Hong Kong Name Practice Area Gautam Agarwal Debt Finance Judy Huang M&A/Private Equity Fergus Saurin Litigation Julia Yu M&A/Private Equity Houston Name Practice Area Adam Garmezy M&A/Private Equity Robert P. Goodin M&A/Private Equity Lance Hancock Capital Markets Will Mabry M&A/Private Equity R.J. Malenfant M&A/Private Equity Mitch McClellan Debt Finance Ryan C. Myers Litigation Erik Shoemaker M&A/Private Equity London Name Practice Area Alex Brodkin Investment Funds Dan Clarke M&A/Private Equity Shane Cranley Antitrust/Competition Adrian Duncan M&A/Private Equity Rachel Greenhalgh M&A/Private Equity Gloria Ho Investment Funds Lloyd Jones Debt Finance James King Investment Funds Daniel McMann M&A/Private Equity Cian O'Connor Tax Sam Sherwood Debt Finance Sophie M. Smith Investment Funds Sam Trowbridge Tax Alexander van der Gaag Debt Finance Tana Wilner Investment Funds Thomas Woodhead Financial Services Regulatory Los Angeles Name Practice Area Shawn Bagdasarian Debt Finance Zachary W. Byer Litigation Sara Campbell M&A/Private Equity Michele M. Cumpston M&A/Private Equity Yimeng Dou Intellectual Property Litigation Mark D. Fahey Intellectual Property Litigation Kimia Ghalambor Real Estate Josh Glucoft Intellectual Property Litigation Whang Ki Josh Jang Debt Finance Jean A. Lee M&A/Private Equity Ashley Neglia Litigation Evan M. Roberts M&A/Private Equity Katie Roddy Real Estate Lauren Schweitzer Intellectual Property Litigation R.E. Scott Syverson M&A/Private Equity Caleb Vesey M&A/Private Equity Munich Name Practice Area Dr. Christoph Jerger M&A/Private Equity Dr. Josef Parzinger Restructuring New York Name Practice Area Jennifer L. Baumgarten Capital Markets Rebecca Blake Chaikin Restructuring Alexandra Chauvin Investment Funds Jordan T. Cohen M&A/Private Equity Romain Dambre M&A/Private Equity Douglas DiMedio M&A/Private Equity Lucy Frey Executive Compensation Scott Fryman Tax Alexander J. Gelski Litigation Chris Hinman Technology & IP Transactions Kyla Jackson Litigation Jean Jeong Investment Funds Shreyas B. Jhaveri Investment Funds John S. Kefer Debt Finance Christine A. Lacku Employment & Labor Sheldon Hunt Laing Investment Funds Kevin Lam Investment Funds Michael J. Milazzo Tax Madelyn A. Morris Litigation Malhar Naik Executive Compensation Alexander J. Nicas Restructuring Arlene J. Ortiz-Leytte M&A/Private Equity Vivek Ratnam Tax Tara L. Rhoades Tax Lukas David Richards M&A/Private Equity Ashley Ross Intellectual Property Litigation Aaron Michael Schleicher Capital Markets Nolan Stanton Real Estate Ben Steadman Debt Finance Allie Strang Litigation Jennifer Wang Investment Funds San Francisco Name Practice Area Michael C. Allers M&A/Private Equity Caitlin Bouey Debt Finance Travis J. Distaso M&A/Private Equity Natalie Flechsig Intellectual Property Litigation Shayne Henry Litigation Ari Levi M&A/Private Equity Simon C. Root M&A/Private Equity Michael Saretsky Environmental Transactions Anna Terteryan Litigation Carol Hsing Wang Tax Shanghai Name Practice Area Yue Qiu Litigation Washington D.C. Name Practice Area Nickolas Barber Litigation Patrick Brown Litigation Haley L. Darling Litigation Nichole DeJulio Intellectual Property Litigation Aaron Ellias Investment Funds Stephanie Greco Antitrust/Competition Sydney Jones Employment & Labor Mike Kilgarriff Litigation Jennie Morawetz Environmental Julie M.K. Siegal Appellate Litigation Thomas Strumpf Investment Funds Andrew L. Stuyvenberg Energy Regulatory Katie M. Sullivan M&A/Private Equity Holly Trogdon Litigation NOTE:  In general the admission date will be October 1, 2020 or such later date when any necessary regulatory requirements have been satisfied.

Oct 1

3 min

Kirkland & Ellis advised Oaktree Capital Management, L.P., a leader among global investment managers specializing in alternative investments, on the successful final close of Oaktree Opportunities Fund XI and its related vehicles (“Opps XI”), with total capital commitments of $15.9 billion. Opps XI is Oaktree’s largest fund in history, exceeding its original target of $15 billion. To date, the Fund has invested or committed to invest approximately 70% of its capital in an attractive mix of opportunities that are diversified across geographies, sectors and asset classes. Read the Oaktree press release The Kirkland team was led by investment funds partners Erica Berthou, Katrina Rowe and Jean Jeong, with the core investment funds team comprised entirely of women lawyers.

Nov 16

1 min

Kirkland & Ells advised Ziff Davis, Inc. (Nasdaq: ZD) on a definitive agreement to sell its Connectivity division to Accenture (NYSE: ACN) for $1.2 billion in cash. Ziff Davis’ Connectivity brands are globally recognized in fixed broadband, mobile and Wi-Fi network design, intelligence, insights, testing and incident detection. These brands, including Ookla, Speedtest, Ekahau, Downdetector and RootMetrics, empower organizations to optimize networks, elevate digital experiences and ensure faster, more reliable connectivity. The transaction is currently expected to close in the coming months, subject to the satisfaction of certain closing conditions and receipt of required regulatory approvals. Read the transaction press release The Kirkland team included corporate lawyers David Klein, Andrew Norwich and Daniel Wolf; tax lawyer Sara Zablotney; executive compensation lawyer Rob Fowler; capital markets lawyers Sophia Hudson and Zoey Hitzert; antitrust & competition lawyer Daniel Zach; and technology & IP transactions lawyer Daisy Darvall.

Mar 3

1 min

Kirkland & Ellis represented trans-Atlantic biotech venture capital firm SR One Capital Management in its successful spinout from GlaxoSmithKline (GSK) and the close of its first independent fund. GSK is the largest investor in the oversubscribed $500 million fund, joined by a global pool of institutional asset managers, endowments, foundations, pension funds and family offices. SR One will seek to continue to build elite biotechnology companies developing innovative medicines that address significant unmet needs. Read SR One’s press release The cross-office team was led by transactional partner Kamran Bajwa and investment funds partners Andrew Day and Jean Jeong and associates Nicole Chiang and Nicole Pennycooke. The team also included investment funds partners Amala Ejikeme and Barry Le Vine, corporate associates Brandon Elliott, Adam Birnbaum and Brian Guerinot, debt finance associate Camille Doom, tax partners Ian Ferreira and Steve Butler and associates Emma Faulkner and Courtney Loyack, investment funds partners Josh Westerholm and Phil Giglio and associate Radhika Kshatriya, financial services regulatory partners Colin Sharpsmith and Lisa Cawley, banking regulatory of counsel Julie Kunetka, executive compensation partner Scott Price, employee benefits partner Liz Dyer, litigation partner Nick Niles, IP litigation partner Mary Mazzello, and international trade and national security associate Luci Hague.

Nov 19

1 min

Kirkland & Ellis advised SR One, a transatlantic life sciences investment firm, on the closing of its second fund (Fund II) at over $600 million, substantially exceeding its target of $500 million. Fund II is the second fund since SR One spun out from GlaxoSmithKline in 2020 to form a fully independent investment firm. The diverse investor base of existing and new limited partners includes endowments, foundations, pharmaceutical companies, pension funds, sovereign wealth funds and family offices. Read SR One’s press release The Kirkland team was led by investment funds partners Jean Jeong, Brian Delaney, Katie St. Peters and Ted Ughetta and associates Sarah Nolan and Soo Young Hong and tax partner Steve Butler and associate Grant Newman.

Mar 28

1 min